Graypoint LLC’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $387K | Buy |
4,954
+761
| +18% | +$59.5K | 0.02% | 380 |
|
|
2025
Q1 | $304K | Buy |
4,193
+862
| +26% | +$62.5K | 0.02% | 405 |
|
|
2024
Q4 | $247K | Buy |
+3,331
| New | +$247K | 0.01% | 447 |
|
|
2024
Q3 | – | Sell |
-4,217
| Closed | -$390K | – | 496 |
|
|
2024
Q2 | $390K | Buy |
4,217
+690
| +20% | +$63.7K | 0.03% | 337 |
|
|
2024
Q1 | $337K | Buy |
+3,527
| New | +$337K | 0.02% | 351 |
|
|
2023
Q3 | – | Sell |
-5,300
| Closed | -$500K | – | 413 |
|
|
2023
Q2 | $500K | Buy |
5,300
+1,101
| +26% | +$104K | 0.05% | 218 |
|
|
2023
Q1 | $347K | Buy |
+4,199
| New | +$347K | 0.04% | 262 |
|